Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure (TXACOVIDPREV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04550338

Recruitment Status : Not yet recruiting

First Posted : September 16, 2020

Last Update Posted : February 16, 2021

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Timothy Ness, MD, University of Alabama at Birmingham

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	December 31, 2022
Estimated Study Completion Date :	March 31, 2023

To Top